Medical Developments International Ltd Market Cap ($30.29 Million)
Market Cap & Net Worth: Medical Developments International Ltd (MVP)
Medical Developments International Ltd market cap. Medical Developments International Ltd (AU:MVP) has a market capitalization of $30.29 Million (AU$42.81 Million) as of November 4, 2026. Listed on the AU stock exchange, this Australia-based company holds position #23534 globally and #878 in its home market, demonstrating a 4.11% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medical Developments International Ltd's stock price AU$0.38 by its total outstanding shares 112658324 (112.66 Million). Also see Medical Developments International Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Medical Developments International Ltd Market Cap History (2015–2026)
Medical Developments International Ltd market cap history from 2015 to 2026. Data shows change from $278.08 Million to $30.29 Million (-17.32% CAGR). Check MVP stock price for real-time trading data and today's change.
Index Memberships
Medical Developments International Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Australia All Ordinaries
AORD
|
$2.01 Trillion | 0.00% | #318 of 495 |
Weight: Medical Developments International Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Medical Developments International Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medical Developments International Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore MVP shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.13x
Medical Developments International Ltd's market cap is 1.13 times its annual revenue
Latest Price to Earnings (P/E) Ratio
470.65x
Medical Developments International Ltd's market cap is 470.65 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $337.58 Million | $15.47 Million | $1.57 Million | 21.82x | 215.15x |
| 2017 | $550.44 Million | $18.35 Million | $1.82 Million | 30.00x | 302.44x |
| 2018 | $341.16 Million | $17.46 Million | $243.00K | 19.54x | 1403.93x |
| 2019 | $684.81 Million | $20.88 Million | $1.04 Million | 32.80x | 659.74x |
| 2020 | $524.03 Million | $22.54 Million | $379.00K | 23.25x | 1382.67x |
| 2021 | $392.24 Million | $25.27 Million | -$12.56 Million | 15.52x | N/A |
| 2022 | $117.98 Million | $21.94 Million | -$12.41 Million | 5.38x | N/A |
| 2023 | $60.58 Million | $32.34 Million | -$5.61 Million | 1.87x | N/A |
| 2024 | $32.28 Million | $33.15 Million | -$40.99 Million | 0.97x | N/A |
| 2025 | $44.24 Million | $39.06 Million | $94.00K | 1.13x | 470.65x |
Competitor Companies of MVP by Market Capitalization
Companies near Medical Developments International Ltd in the global market cap rankings as of November 4, 2026. Also see MVP asset base for a full breakdown of the balance sheet.
Key companies related to Medical Developments International Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Medical Developments International Ltd (2015–2026)
Market capitalization of Medical Developments International Ltd from 2015 to today. Between 2015 and today, Medical Developments International Ltd's market cap moved from $278.08 Million to $ 30.29 Million, with a yearly change of -17.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$30.29 Million | -31.53% |
| 2025 | AU$44.24 Million | +37.04% |
| 2024 | AU$32.28 Million | -46.71% |
| 2023 | AU$60.58 Million | -48.65% |
| 2022 | AU$117.98 Million | -69.92% |
| 2021 | AU$392.24 Million | -25.15% |
| 2020 | AU$524.03 Million | -23.48% |
| 2019 | AU$684.81 Million | +100.73% |
| 2018 | AU$341.16 Million | -38.02% |
| 2017 | AU$550.44 Million | +63.06% |
| 2016 | AU$337.58 Million | +21.40% |
| 2015 | AU$278.08 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Medical Developments International Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.29 Million USD |
| MoneyControl | $30.29 Million USD |
| MarketWatch | $30.29 Million USD |
| marketcap.company | $30.29 Million USD |
| Reuters | $30.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medical Developments International Ltd
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more